Prevention and Treatment of Chlorine Gas Induced Injury to the Pulmonary System

氯气所致肺系统损伤的防治

基本信息

  • 批准号:
    8270062
  • 负责人:
  • 金额:
    $ 12.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-29 至 2012-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chlorine (C12) is a moderately soluble, highly reactive oxidant gas, used extensively for water purification, manufacturing of Pharmaceuticals and chemicals and as a potent disinfectant. Persons exposed to chlorine gas, may experience mild symptoms for the first 6-24 hours (h). However, following this latency period, severe lung injury, characterized by protein-rich edema and the onset of hypoxemia may develop. Presently, the cellular and biochemical events leading to this injury have not been elucidated. We propose that reactive oxygen-chloride and nitrogen intermediates (RONS), formed by the interaction of C12 and its hydrolysis products with nitric oxide (NO), initiate self-propagating chain reactions, the products of which damage alveolar epithelial cells decreasing their ability to produce and secrete surfactant, actively transport sodium (Na+) ions and maintain a tight, semi-permeable barrier. Thus, systemic administration of reactive species scavengers (such as ascorbate, N-acetyl-cysteine (NAC), and deferoxamine, as well as agents that augment surfactant levels, ion transport and paracellular resistance (such as albuterol (a long acting b-agonist) and a recently described peptide based on the lectin region of TNFa (tip peptide), shortly after exposure to C12 will decrease lung injury, morbidity and mortality. This hypothesis will be tested by exposing either confluent monolayers of rat alveolar type II (ATII) epithelial cells (SPECIFIC AIM # 1) or rats (SPECIFIC AIMS #2) to C12 (50-200 ppm for 30 min) and measure the following indices at 0.5, 6, 12 and 24 h post exposure: physiological and biochemical indices of lung function (including surfactant function and composition), ability of the lungs to transport ions in vivo and in vitro and clear pulmonary edema in vivo, levels of inflammatory cytokines in the rat alveolar space and in the plasma, arterial blood gases and pH, as well as levels of low reactive species scavengers (ascorbate, NAC) at 0.5, 6, 12, 24 and 48 h post exposure. These measurements will be repeated following intravenous injections of NAC, ascorbate and deferoxamine as well as albuterol and the tip peptide, every 6 h post exposure for 48 h. In SPECIFIC AIM #3 , we will assess the efficacy of intratracheally instilled ascorbate, NAC, deferoxamine, Infasurf (a surfactant replacement mixture), albuterol and the tip peptide, as well as aerosolized albuterol, in prolonging survival of rats with respiratory failure post C12 exposure. The subject matter of this research is both timely and important: more than 25 million tons of chlorine is manufactured annually in the United States and the majority of this gas is transported by rail and can be used as a chemical weapon.
描述(由申请人提供):氯(C12)是一种中等溶解度、高活性氧化剂气体,广泛用于水净化、药品和化学品生产以及强效消毒剂。暴露于氯气的人员可能会在最初的6-24小时(h)内出现轻微症状。然而,在此潜伏期之后,可能会发生以富含蛋白质的水肿和低氧血症发作为特征的严重肺损伤。目前,导致这种损伤的细胞和生化事件尚未阐明。我们建议,活性氧-氯和氮中间体(RONS),由C12及其水解产物与一氧化氮(NO)的相互作用形成,启动自蔓延的连锁反应,其产物损害肺泡上皮细胞降低其产生和分泌表面活性剂的能力,积极运输钠(Na+)离子,并保持紧密的,半渗透性屏障。因此,在暴露于C12后不久,全身施用反应性物质清除剂(例如抗坏血酸盐、N-乙酰半胱氨酸(NAC)和去铁胺,以及增加表面活性剂水平、离子转运和细胞旁抗性的试剂(例如沙丁胺醇(一种长效β-激动剂)和最近描述的基于TNF α的凝集素区域的肽(tip肽))将降低肺损伤、发病率和死亡率。将通过暴露大鼠肺泡II型(ATII)上皮细胞的融合单层来检验该假设(特定目的#1)或大鼠(具体目标#2)至C12(50-200 ppm,30 min),并在暴露后0.5、6、12和24 h测量以下指数:肺功能生理生化指标(包括表面活性剂功能和组成),肺在体内和体外转运离子的能力以及体内清除肺水肿的能力,在暴露后0.5、6、12、24和48 h,大鼠肺泡腔和血浆中的炎性细胞因子水平、动脉血气和pH值,以及低活性物质清除剂(抗坏血酸盐,NAC)水平。在暴露后48小时,静脉注射NAC、抗坏血酸盐和去铁胺以及沙丁胺醇和tip肽后,每6小时重复这些测量。在具体目标#3中,我们将评估气管内滴注抗坏血酸盐、NAC、去铁胺、Infasurf(表面活性剂替代混合物)、沙丁胺醇和尖端肽以及雾化沙丁胺醇在延长C12暴露后呼吸衰竭大鼠存活率方面的功效。这项研究的主题既及时又重要:美国每年生产2 500多万吨氯,其中大部分通过铁路运输,可用作化学武器。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inhaled matters of the heart.
  • DOI:
    10.14800/crm.997
  • 发表时间:
    2015-09
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Zaky;A. Ahmad;L. Dell’Italia;Leila Jahromi;Lee Ann Reisenberg;S. Matalon;Shama Ahmad
  • 通讯作者:
    A. Zaky;A. Ahmad;L. Dell’Italia;Leila Jahromi;Lee Ann Reisenberg;S. Matalon;Shama Ahmad
Ascorbate and deferoxamine administration after chlorine exposure decrease mortality and lung injury in mice.
  • DOI:
    10.1165/rcmb.2010-0432oc
  • 发表时间:
    2011-08
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    S. Zarogiannis;Asta Jurkuvenaite;S. Fernandez;Stephen F. Doran;A. Yadav;G. Squadrito;E. Postlethwait-
  • 通讯作者:
    S. Zarogiannis;Asta Jurkuvenaite;S. Fernandez;Stephen F. Doran;A. Yadav;G. Squadrito;E. Postlethwait-
Respiratory syncytial virus infection increases chlorine-induced airway hyperresponsiveness.
呼吸道合胞病毒感染会增加氯引起的气道高反应性。
Administration of nitrite after chlorine gas exposure prevents lung injury: effect of administration modality.
氯气暴露后给予亚硝酸盐可预防肺损伤:给药方式的效果。
  • DOI:
    10.1016/j.freeradbiomed.2012.08.007
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    Samal,AndreyA;Honavar,Jaideep;Brandon,Angela;Bradley,KelleyM;Doran,Stephen;Liu,Yanping;Dunaway,Chad;Steele,Chad;Postlethwait,EdwardM;Squadrito,GiuseppeL;Fanucchi,MichelleV;Matalon,Sadis;Patel,RakeshP
  • 通讯作者:
    Patel,RakeshP
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sadis Matalon其他文献

Sadis Matalon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sadis Matalon', 18)}}的其他基金

Mitigation of Chlorine Injury to Mitochondria
减轻氯对线粒体的损​​伤
  • 批准号:
    10204490
  • 财政年份:
    2021
  • 资助金额:
    $ 12.45万
  • 项目类别:
Mitigation of Chlorine Injury to Mitochondria
减轻氯对线粒体的损​​伤
  • 批准号:
    10480741
  • 财政年份:
    2021
  • 资助金额:
    $ 12.45万
  • 项目类别:
Bromine Inhalation Induced Lung Injury: Novel Mechanisms and Treatment Strategies
溴吸入引起的肺损伤:新机制和治疗策略
  • 批准号:
    9567726
  • 财政年份:
    2015
  • 资助金额:
    $ 12.45万
  • 项目类别:
Bromine Inhalation Induced Lung Injury: Novel Mechanisms and Treatment Strategies
溴吸入引起的肺损伤:新机制和治疗策略
  • 批准号:
    8927967
  • 财政年份:
    2015
  • 资助金额:
    $ 12.45万
  • 项目类别:
Finding effective treatments for inhaled chlorine-induced injury related pain
寻找吸入氯引起的损伤相关疼痛的有效治疗方法
  • 批准号:
    8554915
  • 财政年份:
    2012
  • 资助金额:
    $ 12.45万
  • 项目类别:
Finding effective treatments for inhaled chlorine-induced injury related pain
寻找吸入氯引起的损伤相关疼痛的有效治疗方法
  • 批准号:
    8416168
  • 财政年份:
    2012
  • 资助金额:
    $ 12.45万
  • 项目类别:
Adminstration Core
管理核心
  • 批准号:
    8107628
  • 财政年份:
    2010
  • 资助金额:
    $ 12.45万
  • 项目类别:
Novel Treatments of Chlorine Induced Injury to the Cardio-Respiratory Systems-U54
氯引起的心肺系统损伤的新疗法-U54
  • 批准号:
    7932359
  • 财政年份:
    2008
  • 资助金额:
    $ 12.45万
  • 项目类别:
Novel Treatments of Chlorine Induced Injury to the Cardio-Respiratory Systems-U54
氯引起的心肺系统损伤的新疗法-U54
  • 批准号:
    8270066
  • 财政年份:
    2008
  • 资助金额:
    $ 12.45万
  • 项目类别:
Novel Treatments of Chlorine Induced Injury to the Cardio-Respiratory Systems-U54
氯引起的心肺系统损伤的新疗法-U54
  • 批准号:
    7857985
  • 财政年份:
    2008
  • 资助金额:
    $ 12.45万
  • 项目类别:

相似海外基金

抗酸化能を高めたN-acetylcysteineによる老視と白内障抑制機構の解明
阐明具有增强抗氧化能力的N-乙酰半胱氨酸抑制老花眼和白内障的机制
  • 批准号:
    23K15945
  • 财政年份:
    2023
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
  • 批准号:
    10758985
  • 财政年份:
    2023
  • 资助金额:
    $ 12.45万
  • 项目类别:
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
  • 批准号:
    10619173
  • 财政年份:
    2022
  • 资助金额:
    $ 12.45万
  • 项目类别:
High dose acetaminophen with n-acetylcysteine rescue as a novel STAT3 inhibitor with anti-cancer stem cell properties
高剂量对乙酰氨基酚与 n-乙酰半胱氨酸救援作为具有抗癌干细胞特性的新型 STAT3 抑制剂
  • 批准号:
    10517287
  • 财政年份:
    2021
  • 资助金额:
    $ 12.45万
  • 项目类别:
A randomised controlled trial of N-acetylcysteine for the treatment of alcohol use disorder
N-乙酰半胱氨酸治疗酒精使用障碍的随机对照试验
  • 批准号:
    nhmrc : 2001375
  • 财政年份:
    2021
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Clinical Trials and Cohort Studies Grants
High dose acetaminophen with n-acetylcysteine rescue as a novel STAT3 inhibitor with anti-cancer stem cell properties
高剂量对乙酰氨基酚与 n-乙酰半胱氨酸救援作为具有抗癌干细胞特性的新型 STAT3 抑制剂
  • 批准号:
    10368472
  • 财政年份:
    2021
  • 资助金额:
    $ 12.45万
  • 项目类别:
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
  • 批准号:
    10221760
  • 财政年份:
    2020
  • 资助金额:
    $ 12.45万
  • 项目类别:
N-acetylcysteineの骨治癒促進効果の検討
N-乙酰半胱氨酸促进骨愈合作用的考察
  • 批准号:
    20H01118
  • 财政年份:
    2020
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Grant-in-Aid for Encouragement of Scientists
SLE Treatment with N-acetylcysteine
N-乙酰半胱氨酸治疗 SLE
  • 批准号:
    10188441
  • 财政年份:
    2020
  • 资助金额:
    $ 12.45万
  • 项目类别:
SLE Treatment with N-acetylcysteine
N-乙酰半胱氨酸治疗 SLE
  • 批准号:
    10462621
  • 财政年份:
    2020
  • 资助金额:
    $ 12.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了